{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:47:17Z","timestamp":1765961237777,"version":"3.37.3"},"reference-count":40,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003180","name":"Academisch Medisch Centrum","doi-asserted-by":"publisher","award":["Innovation grant 2014"],"award-info":[{"award-number":["Innovation grant 2014"]}],"id":[{"id":"10.13039\/501100003180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2020,3,17]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec><jats:title>Background and aim<\/jats:title><jats:p>It is unclear which patients with Fabry disease (FD) are at risk for progression of white matter lesions (WMLs) and brain infarctions and whether enzyme replacement therapy (ERT) changes this risk. The aim of this study was to determine the effect of ERT and clinical characteristics on progression of WMLs and infarctions on MRI in patients with FD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>MRIs were assessed for WMLs (Fazekas scale), infarctions and basilar artery diameter (BAD). The effect of clinical characteristics (renal and cardiac involvement, cardiovascular risk factors, cardiac complications, BAD) and ERT on WML and infarction progression was evaluated using mixed models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One hundred forty-nine patients were included (median age: 39 years, 38% men, 79% classical phenotype). Median follow-up time was 7 years (range: 0\u201313 years) with a median number of MRIs per patient of 5 (range: 1\u201314), resulting in a total of 852 scans. Variables independently associated with WML and infarction progression were age, male sex and a classical phenotype. Progression of WMLs and infarctions was not affected by adding ERT to the model, neither for the whole group, nor for early treated patients. Progression was highly variable among patients which could not be explained by other known variables such as hypertension, cholesterol, atrial fibrillation and changes in kidney function, left ventricular mass or BAD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Progression of WMLs and cerebral infarctions in FD is mainly related to age, sex and phenotype. Additional effects of established cardiovascular risk factors, organ involvement and treatment with ERT are probably small to negligible.<\/jats:p><\/jats:sec>","DOI":"10.1136\/jnnp-2019-322268","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T21:16:29Z","timestamp":1587503789000},"page":"756-763","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Determinants of cerebral radiological progression in Fabry disease"],"prefix":"10.1136","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-7760","authenticated-orcid":false,"given":"Simon","family":"K\u00f6rver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria G F","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjana R","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla E M","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo N","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Vedolin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel G W","family":"Dijkgraaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"2024111108300564000_91.7.756.1","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"The Lancet"},{"key":"2024111108300564000_91.7.756.2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016090964"},{"key":"2024111108300564000_91.7.756.3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol Genet Metab"},{"key":"2024111108300564000_91.7.756.4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ymgme.2018.08.014","article-title":"Development and clinical consequences of white matter lesions in Fabry disease: a systematic review","volume":"125","author":"K\u00f6rver","year":"2018","journal-title":"Mol Genet Metab"},{"key":"2024111108300564000_91.7.756.5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.143693"},{"key":"2024111108300564000_91.7.756.6","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5069"},{"key":"2024111108300564000_91.7.756.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3666"},{"key":"2024111108300564000_91.7.756.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70170-9"},{"key":"2024111108300564000_91.7.756.9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-37320-0","article-title":"Predictors of objective cognitive impairment and subjective cognitive complaints in patients with Fabry disease","volume":"9","author":"K\u00f6rver","year":"2019","journal-title":"Sci Rep"},{"key":"2024111108300564000_91.7.756.10","doi-asserted-by":"publisher","DOI":"10.1159\/000369293"},{"key":"2024111108300564000_91.7.756.11","doi-asserted-by":"crossref","first-page":"e1413","DOI":"10.1212\/WNL.0000000000006316","article-title":"Enzyme replacement therapy and white matter hyperintensity progression in Fabry disease","volume":"91","author":"Stefaniak","year":"2018","journal-title":"Neurology"},{"key":"2024111108300564000_91.7.756.12","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/STROKEAHA.118.024426","article-title":"Effect of enzyme replacement therapy on basilar artery diameter in male patients with Fabry disease","volume":"50","author":"Miwa","year":"2019","journal-title":"Stroke"},{"key":"2024111108300564000_91.7.756.13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0087054"},{"key":"2024111108300564000_91.7.756.14","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0538"},{"key":"2024111108300564000_91.7.756.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c4249"},{"key":"2024111108300564000_91.7.756.16","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.00430"},{"key":"2024111108300564000_91.7.756.17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"2024111108300564000_91.7.756.18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/8904_2014_342","article-title":"Uncertain diagnosis of Fabry disease in patients with neuropathic pain, angiokeratoma or cornea verticillata: consensus on the approach to diagnosis and follow-up","volume":"17","author":"van der Tol","year":"2014","journal-title":"JIMD Rep"},{"key":"2024111108300564000_91.7.756.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.09.001"},{"key":"2024111108300564000_91.7.756.20","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2014-102872"},{"key":"2024111108300564000_91.7.756.21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cge.12449","article-title":"Diagnostic dilemmas in Fabry disease: a case series study on Gla mutations of unknown clinical significance","volume":"88","author":"Smid","year":"2015","journal-title":"Clin Genet"},{"key":"2024111108300564000_91.7.756.22","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70124-8"},{"key":"2024111108300564000_91.7.756.23","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.149.2.351"},{"key":"2024111108300564000_91.7.756.24","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(93)90041-V"},{"key":"2024111108300564000_91.7.756.25","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000123264.40498.B6"},{"key":"2024111108300564000_91.7.756.26","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.1910170215"},{"key":"2024111108300564000_91.7.756.27","unstructured":"Kidney Disease Improving Global Outcomes (KDIGO) . Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. In: Kidney international supplements. CKD Work Group, 2013: 1\u2013150."},{"key":"2024111108300564000_91.7.756.28","doi-asserted-by":"publisher","DOI":"10.1161\/hy0302.104674"},{"key":"2024111108300564000_91.7.756.29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00924.x"},{"key":"2024111108300564000_91.7.756.30","unstructured":"R: A language and environment for statistical computing [program] . 3.5.1 version. Vienna, Austria: R Foundation for Statistical Computing, 2018."},{"key":"2024111108300564000_91.7.756.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcm.2016.02.012"},{"key":"2024111108300564000_91.7.756.32","unstructured":"Christensen RHB . A tutorial on fitting cumulative link mixed models with clmm2 from the ordinal package. 2019."},{"key":"2024111108300564000_91.7.756.33","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v045.i03","article-title":"mice : Multivariate Imputation by Chained Equations in R","volume":"45","author":"Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"2024111108300564000_91.7.756.34","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2017-104863"},{"key":"2024111108300564000_91.7.756.35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173358"},{"key":"2024111108300564000_91.7.756.36","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1212\/WNL.0000000000002673","article-title":"Determinants of white matter hyperintensity burden in patients with Fabry disease","volume":"86","author":"Rost","year":"2016","journal-title":"Neurology"},{"key":"2024111108300564000_91.7.756.37","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000116"},{"key":"2024111108300564000_91.7.756.38","doi-asserted-by":"publisher","DOI":"10.1159\/000113863"},{"key":"2024111108300564000_91.7.756.39","first-page":"875","article-title":"Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement","volume":"27","author":"van den Heuvel","year":"2006","journal-title":"AJNR Am J Neuroradiol"},{"key":"2024111108300564000_91.7.756.40","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s13244-018-0664-8","article-title":"Neuroimaging in Fabry disease: current knowledge and future directions","volume":"9","author":"Cocozza","year":"2018","journal-title":"Insights Imaging"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2019-322268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T16:31:57Z","timestamp":1731342717000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2019-322268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,6,18]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/jnnp-2019-322268"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2019-322268","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"type":"print","value":"0022-3050"},{"type":"electronic","value":"1468-330X"}],"subject":[],"published":{"date-parts":[[2020,4,21]]}}}